UnitedHealthvsZymeworks

UNH and ZYME stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$349.91

Value $318B

-5.42%
UNH's page

UnitedHealth (UNH) has a market value of $318B and Zymeworks (ZYME) $1.8B. Over the last year, with dividends, UNH moved +24.3% and ZYME +39.5%. The P/E is 20.0 for UNH and 41.5 for ZYME. Dividend yield: UNH 2.59%, ZYME none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    UNH$318B

    ZYME$1.8B

    UNH is 177 times ZYME

  • Revenue, 12 months

    UNH$450B

    ZYME$266M

    UNH is 1,691 times ZYME

  • Net income, 12 months

    UNH$15.9B

    ZYME$43M

    UNH is 367 times ZYME

  • Operating margin

    UNH5.3%

    ZYME16.6%

    11.3 points apart

  • ROIC

    UNH11.3%

    ZYME16.0%

    4.7 points apart

  • P/E

    UNH20.0

    ZYME41.5

    ZYME is 2.1 times UNH

  • Dividend yield

    UNH2.6%

    ZYME0.0%

    2.6 points apart

  • 5-year return

    UNH-5.1%

    ZYME+29.9%

    35.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

UNH-5.1%

ZYME+29.9%

5010015020222023202420252026
Returns by period
PeriodUNHWith dividendsZYMEWith dividends
1 year since November 14, 2025+24.3%Price +21.1%+39.5%Price +39.5%
3 years since November 17, 2023-22.6%-8.2% a yearPrice -27.3%+215.5%+46.7% a yearPrice +215.5%
5 years since November 16, 2021-5.1%-1.0% a yearPrice -13.3%+29.9%+5.4% a yearPrice +29.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

UNHUnitedHealthZYMEZymeworks

Valuation

UNHZYME
Valuation
Price$349.91$26.04
Market value$318B$1.8B
Enterprise value (EV)$363B$2.0B
P/E20.041.5
P/E, 5-year median25.0–
P/B3.17.0
EV/EBIT15.246.1
Free cash flow yield7.2%–

Results and growth

UNHZYME
Results and growth
Revenue, 12 months$450B$266M
Net income, 12 months$15.9B$43M
Free cash flow, 12 months$22.8B-$113M
Earnings per share, 12 months$17.52$0.63
Revenue growth, year on year11.8%38.9%
Revenue growth a year, past+11.7%over 5 years+22.2%over 5 years
EPS growth a year, past-3.8%over 5 years–

Margins and returns on capital

UNHZYME
Margins and returns on capital
Gross margin88.3%–
Operating margin5.3%16.6%
Net margin3.5%16.3%
ROIC11.3%16.0%
ROE15.5%19.9%

Balance sheet

UNHZYME
Balance sheet
Cash$28.5B$100M
Total debt$74.3B$392M
Net debt / EBITDA1.65.0
Interest cover6.2×–

Dividends and buybacks

UNHZYME
Dividends and buybacks
Dividend yield2.6%–
Dividend per share, 12 months$9.06–
Dividend growth a year, past+12.6%over 5 years–
Buyback yield1.8%2.3%
Shareholder yield4.3%2.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: UNH or ZYME

Didn't find what you were looking for?

Ask us
Which is bigger, UnitedHealth or Zymeworks?

By market value, UnitedHealth ($318B) is about 176.7 times Zymeworks ($1.8B), at today's prices.

How did UNH and ZYME stock do over the last 5 years?

Since November 16, 2021, UNH's price moved -13.3% and ZYME's +29.9%. With dividends: UNH -5.1% (-1.0% a year), ZYME +29.9% (+5.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, UNH or ZYME?

The dividend yield at today's price is 2.59% for UnitedHealth and none for Zymeworks. Over the last twelve months they paid $9.06 and – per share.

What is the P/E of UNH and ZYME?

At today's price, the P/E is 20.0 for UNH and 41.5 for ZYME. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, UnitedHealth or Zymeworks?

Over the last twelve months, the net margin was 3.5% for UnitedHealth and 16.3% for Zymeworks, and the operating margin 5.3% and 16.6%. Revenue was $450B and $266M.

Which is the better investment, UnitedHealth or Zymeworks?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.